Citation 14145

LIM,BO: CHOUE,RW: LEE,HY: SEONG,NS: KIM,JD:. (2003). EFFECT OF THE FLAVONOID COMPONENTS OBTAINED FROM SCUTELLARIA RADIX ON THE HISTAMINE, IMMUNOGLOBULIN E AND LIPID PEROXIDATION OF SPLEEN LYMPHOCYTES OF SPRAGUE-DAWLEY RATS.. 67(5)

Citation Details

Title	EFFECT OF THE FLAVONOID COMPONENTS OBTAINED FROM SCUTELLARIA RADIX ON THE HISTAMINE, IMMUNOGLOBULIN E AND LIPID PEROXIDATION OF SPLEEN LYMPHOCYTES OF SPRAGUE-DAWLEY RATS.
Authors	LIM,BO: CHOUE,RW: LEE,HY: SEONG,NS: KIM,JD:
Year	2003
Volume	67
Issue	5

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	IMMUNOGLOBULIN-E INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-3-5-6'-7-PENTAHYDROXY:	INACTIVE
2	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-3-5-6'-7-PENTAHYDROXY:	INACTIVE
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-3-5-6'-7-PENTAHYDROXY:	ACTIVE
4	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-3-5-6'-7-PENTAHYDROXY:	ACTIVE
5	IMMUNOGLOBULIN-E INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-3-5-6'-7-PENTAHYDROXY:	INACTIVE
6	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-3-5-6'-7-PENTAHYDROXY:	INACTIVE
7	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-3-5-6'-7-PENTAHYDROXY:	ACTIVE
8	IMMUNOGLOBULIN-E INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONOSIDE	ACTIVE
9	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONOSIDE	INACTIVE
10	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONOSIDE	INACTIVE
11	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONOSIDE	ACTIVE
12	IMMUNOGLOBULIN-E INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONOSIDE	ACTIVE
13	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONOSIDE	INACTIVE
14	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONOSIDE	ACTIVE
15	IMMUNOGLOBULIN-E INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANHUANGENIN	ACTIVE
16	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANHUANGENIN	INACTIVE
17	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANHUANGENIN	ACTIVE
18	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANHUANGENIN	ACTIVE
19	IMMUNOGLOBULIN-E INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANHUANGENIN	ACTIVE
20	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANHUANGENIN	INACTIVE
21	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GANHUANGENIN	ACTIVE
22	IMMUNOGLOBULIN-E INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	ACTIVE
23	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	INACTIVE
24	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	INACTIVE
25	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	ACTIVE
26	IMMUNOGLOBULIN-E INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	ACTIVE
27	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	INACTIVE
28	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	INACTIVE

Citation 14145

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1